Fred Kamal is the founder of 4D Molecular Therapeutics. 4D Molecular Therapeutics has raised $473M in total funding.
Fred Kamal, PhD, is a co-founder of 4D Molecular Therapeutics, a clinical-stage gene therapy company. He serves as the President and Chief Operating Officer of the company, focusing on developing product candidates using targeted and evolved AAV vectors.
Full founder directory · Investor directory · Company funding database · Fundraising library